Ping An concludes clinical study for world’s first OCT retinal disease screening system
The ophthalmologist operating the optical coherence tomography (OCT) retinal disease screening system (PRNewsfoto/Ping An Insurance (Group) Compa)
NS Medical Devices is using cookies
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X